Journal Report

CANCER BIOLOGY & MEDICINE

Download PDF
Journal Information
Journal Title
CANCER BIOLOGY & MEDICINE
Publisher
CHINA ANTI-CANCER ASSOC
ISSN
2095-3941
E-ISSN
2095-3941
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell–macrophage chemokine axis in hepatocellular carcinoma
Jiahao Huang, Boyang Yi, Kuo Qi et al.
2026-11-4 Pages 1-21
DOI: 10.20892/j.issn.2095-3941.2026.0468
An integrated CT/MRI diagnostic system for pancreatic cystic lesions that supports pathological classification and risk stratification
Xiaonan Cui, Houpu Liu, Sunyi Zheng et al.
2026-10-29 Vol. 23 Issue 10 Pages 1495-1512
DOI: 10.20892/j.issn.2095-3941.2026.0566
DNA methylation-based classification and molecular characteristics of spinal cord gliomas with wildtype histone H3 reveal differences between adult and pediatric pilocytic astrocytoma
Ruichao Chai, Huiyuan Chen, Songyuan An et al.
2026-10-29 Pages 1-19
DOI: 10.20892/j.issn.2095-3941.2026.0376
RHBDF2 stabilizes SEC62 to sustain MDR1 biosynthesis and chemoresistance in breast cancer
Yuanyuan Song, Lei Wang, Yumeng Liu et al.
2026-10-27 Pages 1-21
DOI: 10.20892/j.issn.2095-3941.2026.0488
Targeting KRAS condensates to counter therapeutic resistance in colorectal cancer
Yi Zhang, Xingwen Wang, Jing Hu et al.
2026-10-27 Pages 1-6
DOI: 10.20892/j.issn.2095-3941.2026.0573
Erratum to Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway
Lianmei Zhao, Jie Li, Yueping Liu et al.
2026-10-14 Pages 1-5
DOI: 10.20892/j.issn.2095-3941.2026.0738
A bispecific EGFR × HER3 antibody–drug conjugate for later-line recurrent or metastatic nasopharyngeal carcinoma: insights from BL-B01D1-303
Huaqiang Zhou, Jiayi Shen, Jiaqing Liu et al.
2026-9-23 Pages 1-9
DOI: 10.20892/j.issn.2095-3941.2026.0336
Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial
Mengjie Li, Caixia Liu, Fengming Ran et al.
2026-9-17 Pages 1-14
DOI: 10.20892/j.issn.2095-3941.2026.0311
Revisiting the immunosuppressive microenvironment in hepatocellular carcinoma: a functional taxonomy of immune cells and therapeutic targeting
Jiaqian Zhang, Siwen Li, Xianglong Ma et al.
2026-9-15 Pages 1-26
DOI: 10.20892/j.issn.2095-3941.2026.0154
Erratum to From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management
Junnan Xu, Kun Fang, Xiaoxi Li et al.
2026-9-8 Pages 1-1
DOI: 10.20892/j.issn.2095-3941.2026.0704
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 19:06